Don’t forget fibratesA major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization. New protease inhibitor showing promise for hepatitis CEarly study suggests experimental drug telaprevir offers option for patients who have not responded to standard treatment First-in-class medications target RA and type 2 diabetes Hybrid therapy tops for H. pylori infection Two-week combined strategy achieves superior eradication rates Ask the Experts: Treating UTI in patients with poor renal function Is Macrobid or nitrofurantoin effective for UTI in patient's with poor renal function, i.e. CrCl<30mL/min? Links found between diet, inflammatory bowel disease Olive oil is protective, high animal protein intake may raise risk OPA voices concerns over province's drug system reforms Berinert: first treatment for hereditary angioedema approved in Canada CPhA expresses disappointment with Ontario announcement 2010 Canadian hypertension guidelines now available First Previous 2140 2141 2142 2143 2144 Next Last
